Ask if Zeposia Is Being Used for Ulcerative Colitis or Multiple Sclerosis

June 2022

Zeposia (ozanimod) will be a new oral, once-daily capsule for ulcerative colitis (UC) in adults.

Zeposia is already used for multiple sclerosis.

Now you may see it used by some patients with advanced ulcerative colitis who don't respond to or don't tolerate usual meds (azathioprine, etc) or a biologic (infliximab, etc).

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Practice Work as a Team to Navigate Staffing Shortages
Bites & Stings Sort Through the Swarm of Insect Repellents
COVID-19 Be Familiar With Evusheld for Prevention of COVID-19
Travel Medicine Listen for Questions About Preventing Blood Clots During Travel
Practice Optimize Care for Patients With Disabilities
Ulcerative Colitis Ask if Zeposia Is Being Used for Ulcerative Colitis or Multiple Sclerosis
Specialty Meds Understand Unique Considerations With Specialty Meds
Cancer Help Overcome Barriers With Opioid Rxs for Cancer Pain
Med Safety Improve Safety With PDE5 Inhibitors

Ask if Zeposia Is Being Used for Ulcerative Colitis or Multiple Sclerosis

Practical advice for a better career, with unlimited access to CE

Table of Contents